IDEAS home Printed from https://ideas.repec.org/a/plo/pcbi00/1000796.html
   My bibliography  Save this article

Optimal Drug Synergy in Antimicrobial Treatments

Author

Listed:
  • Joseph Peter Torella
  • Remy Chait
  • Roy Kishony

Abstract

The rapid proliferation of antibiotic-resistant pathogens has spurred the use of drug combinations to maintain clinical efficacy and combat the evolution of resistance. Drug pairs can interact synergistically or antagonistically, yielding inhibitory effects larger or smaller than expected from the drugs' individual potencies. Clinical strategies often favor synergistic interactions because they maximize the rate at which the infection is cleared from an individual, but it is unclear how such interactions affect the evolution of multi-drug resistance. We used a mathematical model of in vivo infection dynamics to determine the optimal treatment strategy for preventing the evolution of multi-drug resistance. We found that synergy has two conflicting effects: it clears the infection faster and thereby decreases the time during which resistant mutants can arise, but increases the selective advantage of these mutants over wild-type cells. When competition for resources is weak, the former effect is dominant and greater synergy more effectively prevents multi-drug resistance. However, under conditions of strong resource competition, a tradeoff emerges in which greater synergy increases the rate of infection clearance, but also increases the risk of multi-drug resistance. This tradeoff breaks down at a critical level of drug interaction, above which greater synergy has no effect on infection clearance, but still increases the risk of multi-drug resistance. These results suggest that the optimal strategy for suppressing multi-drug resistance is not always to maximize synergy, and that in some cases drug antagonism, despite its weaker efficacy, may better suppress the evolution of multi-drug resistance.Author Summary: The use of antibiotics against bacterial infections has led to the emergence of multi-drug resistant pathogens such as tuberculosis and MRSA. In order to control resistance, clinicians have increasingly turned to multi-antibiotic therapies. The common wisdom is to use combinations of drugs that act synergistically to kill the infection, but the impact of drug synergy on the evolution of resistance is unclear. Using mathematical simulations of an in vivo infection model, we asked what level of drug synergy would minimize the risk of multi-drug resistance while preserving the efficacy of treatment. We found that synergy may increase or decrease the risk of multi-drug resistance in a given treatment, depending on infection properties such as mutation rate and the availability of resources. Surprisingly, under conditions of strong competition for resources within the host, we found that maximal synergy—currently favored in clinical settings—can actually increase the risk of multi-drug resistance. Our results identify conditions under which drug synergy exacerbates the problem of multi-drug resistance, and offer guidelines for the selection of drug pairs that suppress it.

Suggested Citation

  • Joseph Peter Torella & Remy Chait & Roy Kishony, 2010. "Optimal Drug Synergy in Antimicrobial Treatments," PLOS Computational Biology, Public Library of Science, vol. 6(6), pages 1-9, June.
  • Handle: RePEc:plo:pcbi00:1000796
    DOI: 10.1371/journal.pcbi.1000796
    as

    Download full text from publisher

    File URL: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1000796
    Download Restriction: no

    File URL: https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1000796&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pcbi.1000796?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Remy Chait & Allison Craney & Roy Kishony, 2007. "Antibiotic interactions that select against resistance," Nature, Nature, vol. 446(7136), pages 668-671, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jeff Maltas & Kevin B Wood, 2019. "Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance," PLOS Biology, Public Library of Science, vol. 17(10), pages 1-34, October.
    2. Jason Karslake & Jeff Maltas & Peter Brumm & Kevin B Wood, 2016. "Population Density Modulates Drug Inhibition and Gives Rise to Potential Bistability of Treatment Outcomes for Bacterial Infections," PLOS Computational Biology, Public Library of Science, vol. 12(10), pages 1-21, October.
    3. Daniel P. Newton & Po-Yi Ho & Kerwyn Casey Huang, 2023. "Modulation of antibiotic effects on microbial communities by resource competition," Nature Communications, Nature, vol. 14(1), pages 1-12, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Philip Gerlee & Linnéa Schmidt & Naser Monsefi & Teresia Kling & Rebecka Jörnsten & Sven Nelander, 2013. "Searching for Synergies: Matrix Algebraic Approaches for Efficient Pair Screening," PLOS ONE, Public Library of Science, vol. 8(7), pages 1-10, July.
    2. Marianne Bauer & Isabella R Graf & Vudtiwat Ngampruetikorn & Greg J Stephens & Erwin Frey, 2017. "Exploiting ecology in drug pulse sequences in favour of population reduction," PLOS Computational Biology, Public Library of Science, vol. 13(9), pages 1-17, September.
    3. Elsa Hansen & Jason Karslake & Robert J Woods & Andrew F Read & Kevin B Wood, 2020. "Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations," PLOS Biology, Public Library of Science, vol. 18(5), pages 1-20, May.
    4. Greenspoon, Philip B. & Mideo, Nicole, 2017. "Evolutionary rescue of a parasite population by mutation rate evolution," Theoretical Population Biology, Elsevier, vol. 117(C), pages 64-75.
    5. Chih-Wei Chen & Nadja Leimer & Egor A. Syroegin & Clémence Dunand & Zackery P. Bulman & Kim Lewis & Yury S. Polikanov & Maxim S. Svetlov, 2023. "Structural insights into the mechanism of overcoming Erm-mediated resistance by macrolides acting together with hygromycin-A," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    6. Daniel Nichol & Peter Jeavons & Alexander G Fletcher & Robert A Bonomo & Philip K Maini & Jerome L Paul & Robert A Gatenby & Alexander RA Anderson & Jacob G Scott, 2015. "Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance," PLOS Computational Biology, Public Library of Science, vol. 11(9), pages 1-19, September.
    7. Jeff Maltas & Kevin B Wood, 2019. "Pervasive and diverse collateral sensitivity profiles inform optimal strategies to limit antibiotic resistance," PLOS Biology, Public Library of Science, vol. 17(10), pages 1-34, October.
    8. Eva Stadler & Mohamed Maiga & Lukas Friedrich & Vandana Thathy & Claudia Demarta-Gatsi & Antoine Dara & Fanta Sogore & Josefine Striepen & Claude Oeuvray & Abdoulaye A. Djimdé & Marcus C. S. Lee & Lau, 2023. "Propensity of selecting mutant parasites for the antimalarial drug cabamiquine," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    9. Roger Guimerà & Marta Sales-Pardo, 2013. "A Network Inference Method for Large-Scale Unsupervised Identification of Novel Drug-Drug Interactions," PLOS Computational Biology, Public Library of Science, vol. 9(12), pages 1-9, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pcbi00:1000796. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ploscompbiol (email available below). General contact details of provider: https://journals.plos.org/ploscompbiol/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.